195 related articles for article (PubMed ID: 8854762)
1. [Targeted chemotherapy of hepatocellular carcinoma using Lipiodol as a carrier].
Konno T; Oda T; Nagamitsu A; Tabaru K; Yamashita R; Kai Y
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1392-9. PubMed ID: 8854762
[TBL] [Abstract][Full Text] [Related]
2. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol].
Konno T; Tabaru K; Isogai M; Nagamitsu A; Oda T
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681
[TBL] [Abstract][Full Text] [Related]
3. [Targeting cancer chemotherapy using lipiodol as a carrier of anticancer drugs for hepatocellular carcinoma].
Konno T; Maeda H
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1043-50. PubMed ID: 2839112
[TBL] [Abstract][Full Text] [Related]
4. [Arterial infusion chemotherapy with SMAN CS-Lipiodol for hepatocellular carcinoma evaluation of infusion method].
Takizawa K; Obuchi M; Honda M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2117-22. PubMed ID: 9388522
[TBL] [Abstract][Full Text] [Related]
5. [Arterial administration of oily anticancer agents dissolved in lipiodol fluid in recurrence of hepatoma after hepatic resection and in metastatic liver cancer].
Ohtsuka N; Konno T
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1351-8. PubMed ID: 2837992
[TBL] [Abstract][Full Text] [Related]
6. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].
Takizawa K; Honda M; Obuchi M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683
[TBL] [Abstract][Full Text] [Related]
7. [Targeting chemotherapy of hepatocellular carcinoma by arterial administration of anticancer agents dissolved in lipiodol].
Konno T
Gan To Kagaku Ryoho; 1987 Feb; 14(2):373-80. PubMed ID: 3028275
[TBL] [Abstract][Full Text] [Related]
8. [A case of hepatocellular carcinoma with tumor thrombus in the right atrium successfully treated by arterial administration of lipiodol-SMANCS].
Yamada K; Sato T; Yamada A; Tanaka S; Fujii S; Matuo R; Murata K; Manabe T; Oda J
Gan To Kagaku Ryoho; 1999 Feb; 26(3):361-4. PubMed ID: 10065101
[TBL] [Abstract][Full Text] [Related]
9. [Two cases of long-term survival with hepatocellular carcinoma following targeting therapy with SMANCS/lipiodol].
Inoue Y; Nakamura H
Gan To Kagaku Ryoho; 1996 Jan; 23(1):99-101. PubMed ID: 8546478
[TBL] [Abstract][Full Text] [Related]
10. [Effect of arterial administration of a high molecular weight anti-tumor agent styrene maleic acid neocarzinostatin for multiple small liver cancer].
Ikeda K; Saitoh S; Kumada H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():19-23. PubMed ID: 9512682
[TBL] [Abstract][Full Text] [Related]
11. [Repeated arterial infusion of zinostatin stimalamer using port for advanced hepatocellular carcinoma].
Yoshikawa M; Ebara M; Fukuda H; Sugiura N; Saisho H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():30-3. PubMed ID: 9512684
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of transcatheter hepatic segmental or subsegmental infusion of SMANCS for treatment of hepatocellular carcinoma].
Inoue Y; Tomoda K; Oi H; Nakamura H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():56-63. PubMed ID: 9512689
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of carcinomatous effusion with oily anticancer agents dissolved in lipiodol].
Kimura M; Konno T; Oda T; Yamashita R
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1579-82. PubMed ID: 2167635
[TBL] [Abstract][Full Text] [Related]
14. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].
Hasegawa I; Hirashima N
Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632
[TBL] [Abstract][Full Text] [Related]
15. [A case of massive hepatoma which responded to SMANCS/Lipiodol regimen with intra-arterial infusion].
Kubo M; Fuchigami T; Murata S; Konno T; Maeda H
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2953-6. PubMed ID: 2551233
[TBL] [Abstract][Full Text] [Related]
16. [Use of a lipid lymphographic agent, lipiodol, as a carrier of high molecular weight antitumor agent, smancs, for hepatocellular carcinoma].
Konno T; Maeda H; Yokoyama I; Iwai K; Ogata K; Tashiro S; Uemura K; Mochinaga M; Watanabe E; Nakakuma K; Morinaga T; Miyauchi Y
Gan To Kagaku Ryoho; 1982 Nov; 9(11):2005-15. PubMed ID: 6307179
[TBL] [Abstract][Full Text] [Related]
17. [Principle and therapeutic effect of lipophilic anticancer agent [SMANCS/lipiodol]: selective targeting with oily contrast medium].
Maeda H
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3323-31. PubMed ID: 2552930
[TBL] [Abstract][Full Text] [Related]
18. Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases.
Kenji J; Hyodo I; Tanimizu M; Tanada M; Nishikawa Y; Hosokawa Y; Mandai K; Moriwaki S
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-71-S6-80. PubMed ID: 9151920
[TBL] [Abstract][Full Text] [Related]
19. [Arterial infusion of SMANCS-Lipiodol for advanced hepatocellular carcinoma].
Miura K; Nakao N; Yoshimoto A; Yamano T; Inoue J; Takayasu Y
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():51-5. PubMed ID: 9512688
[TBL] [Abstract][Full Text] [Related]
20. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
Jin-no K
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
